Literature DB >> 31709644

The miR-28-5p-CAMTA2 axis regulates colon cancer progression via Wnt/β-catenin signaling.

Xiao-Feng Luan1, Lei Wang1, Xue-Feng Gai1.   

Abstract

BACKGROUND: Colon cancer is the third most commonly diagnosed cancer with high morbidity and mortality. Calmodulin-binding transcription activator 2 (CAMTA2) belongs to the calmodulin-binding transcription activator protein family. The functional role of CAMTA2 in colon cancer development remains unclear. Our research found out that CAMTA2 was high-level expressed in colon cancer, and the upregulated CAMTA2 expression was markedly correlated with poor survival. Functional experiments showed that knockdown of CAMTA2 repressed colon cancer cell proliferation/migration in vitro and attenuated proliferation in vivo. In additional, CAMTA2 expression was controlled by miR-28-5p via posttranscriptional regulation and miR-28-5p expression was reversely correlated with CAMTA2 expression in colon cancer. Moreover, enforced miR-28-5p expression downregulated the expression of CAMTA2 significantly and the restoration of CAMTA2 expression abolished the inhibitory effect of miR-28-5p on colon cancer cell proliferation and metastasis. Mechanistically, overexpression of miR-28-5p suppressed Wnt/β-catenin signaling and the inhibitory could be partly abolished by overexpression of CAMTA2. In summary, our findings reveal that miR-28-5p/CAMTA2 axis plays a critical role in human colon cancer, which might be a promising diagnosis and therapeutic target for colon cancer treatment.
© 2019 The Authors. Journal of Cellular Biochemistry published by Wiley Periodicals, Inc.

Entities:  

Keywords:  CAMTA2; Wnt/β-catenin; colon cancer; miR-28-5p

Year:  2019        PMID: 31709644     DOI: 10.1002/jcb.29536

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer.

Authors:  Ji-Lin Li; Ke-Zhi Li; Ming-Zhi Xie; Yan-Ping Tang; Yin-Lin Tang; Bangli Hu
Journal:  Dis Markers       Date:  2020-05-20       Impact factor: 3.434

2.  Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.

Authors:  Zhiguo Zhu; Yaoan Wen; Chunxiang Xuan; Qingping Chen; Qian Xiang; Jiamin Wang; Yangzhou Liu; Lianmin Luo; Shankun Zhao; Yihan Deng; Zhigang Zhao
Journal:  FEBS Open Bio       Date:  2020-03-19       Impact factor: 2.693

Review 3.  The Current Status of SSRP1 in Cancer: Tribulation and Road Ahead.

Authors:  Shengnan Jia; Baofeng Guo; Lihui Wang; Liping Peng; Ling Zhang
Journal:  J Healthc Eng       Date:  2022-04-13       Impact factor: 3.822

4.  Radiation-response in primary fibroblasts of long-term survivors of childhood cancer with and without second primary neoplasms: the KiKme study.

Authors:  Caine Lucas Grandt; Lara Kim Brackmann; Alicia Poplawski; Heike Schwarz; Willempje Hummel-Bartenschlager; Thomas Hankeln; Christiane Kraemer; Federico Marini; Sebastian Zahnreich; Iris Schmitt; Philipp Drees; Johanna Mirsch; Desiree Grabow; Heinz Schmidberger; Harald Binder; Moritz Hess; Danuta Galetzka; Manuela Marron
Journal:  Mol Med       Date:  2022-09-06       Impact factor: 6.376

5.  Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosome‑mediated circ‑HMGCS1 via the miR‑34a‑5p/SGPP1 axis.

Authors:  Juan He; Huaping Zhao; Xing Liu; Dongmei Wang; Yong Wang; Yanqiu Ai; Jianjun Yang
Journal:  Oncol Rep       Date:  2020-09-29       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.